InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Grund Nicholas. Officer active across 2 companies, notably Akebia Therapeutics, Inc.. In total, 3 reports have been published. History available since 31 January 2024. The latest transaction was disclosed on 31 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
3 of 3 declarations